EPCAM and liver cancer: Taken together, our results suggest that the Hippo-YAP1 pathway might be involved in the pathogenesis of liver cancers with stemness, such as EpCAM(+)/K19(+) HCCs and cHC-CCs, which exhibit aggressive biological behavior.